QIAGEN powered by

Webinars and events

« All Events

  • This event has passed.
Event Series Event Series: Clinical Oncology Summit

How to improve your existing pipeline for somatic mutation analysis, interpretation and reporting: Part 1

April 27, 2023 @ 10:00 am - 12:00 pm

We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18, 2023.

The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of comprehensive genomic profiling, and educational presentations on the latest databases, software, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis, interpretation and reporting, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time, improve operational costs, and scale for higher throughput.

Meet the speakers and view the full agenda here.

Register for event

Details

Date: April 27, 2023
Time:
 10:00 am - 12:00 pm
Register for event

Venue:

View Venue Website
Event Categories:
,

Other

Category
Clinical, Event

Related Events

Register for event

On-demand Webinars


  • On-demand webinar: Get insights into the bioinformatics analysis of Nanopore sequencing data for SARS-CoV-2

    The study of the COVID-19 pandemic often involves sequencing the SARS-CoV-2 virus using Illumina, Nanopore, IonTorrent and Sanger technologies alone or in combination. Depending on the sampling and library preparation method used, this can involve metatranscriptomic data of varying viral content. In this webinar tutorial, you will learn about: Best practices for ...

    WATCH NOW
  • On-demand webinar: Discover hidden relationships in your toxicological studies with QIAGEN IPA

    QIAGEN Ingenuity Pathway Analysis (IPA) reveals the hidden upstream drivers and downstream outcomes in your toxicogenomics datasets. Put those results into context using Analysis Match with over 50,000 pre-analyzed datasets for human, mouse and rat. Explain the causes and effects in your studies so you can generate hypotheses to develop better drugs, biomarkers and mo...

    WATCH NOW
  • On-demand web seminar: Enabling high-throughput genomic surveillance of emerging SARS-CoV-2 strains

    Join our webinar to discover a scalable workflow for SARS-CoV-2 whole genome sequencing to accelerate detection of variants such as B.1.1.7 and B.1.351. In this new webinar, we will describe how QIAGEN’s QIAseq SARS-CoV-2 integrated workflow combines QIAseq chemistries and CLC Genomics Analysis software to deliver a scalable, high-performance solution for sequencing...

    WATCH NOW
  • On-demand webinar: Investigation of Somatic and Germline Variants by COSMIC, HGMD and QIAGEN Databases

    Identifying and studying actionable variants is of great interest to many investigators. In this webinar, COSMIC, HGMD and QIAGEN database will be introduced for annotation and investigation of both somatic and germline variants. Attendees will learn how to use QIAGEN Clinical Insight Interpret Translational (QCI-IT) to identify key actionable variants from whole geno...

    WATCH NOW
  • On-demand Webinar: Whole exome sequencing (WES) helps understand exceptional survival in rare sarcoma patient

    In this webinar presented by Rockefeller University, Danbury Hospital and QDI, we present a unique case study of a treatment-naïve patient with aggressive metastatic uLMS who has experienced long-term survival. Using whole exome sequencing (WES), we analyzed 5 tumors to identify mechanisms of uLMS tumor growth and metastasis in this patient. Attendees of this webi...

    WATCH NOW
  • On-demand Webinar: Accelerate R&D in new cancer drug development

    Learn about a new database that helps you accelerate cancer drug development. This is the ONE tool that all translational research programs need to accelerate cancer drug R&D. Free trials offered to all attendees.   Webinar Abstract The paradigm of predictive biomarkers of therapeutic responses to drug intervention has dramatically transformed cancer...

    WATCH NOW
  • On-demand Webinar: Comprehensive Molecular Tumor Analysis with Alacris Theranostics

    Join Dr. Marie-Laure Yaspo, Co-Founder and Chief Scientific Officer of Alacris Theranostics, as she discusses the development, application, and analysis of the Comprehensive Molecular Tumor Analysis (CMTA) test for cancer patients. Precision oncology approaches have made great strides harnessing individual tumor mutation profiles to guide targeted therapy choic...

    WATCH NOW
Sample to Insight